Cargando…
Cancel cancer: The immunotherapeutic potential of CD200/CD200R blockade
Immune checkpoint molecules function to inhibit and regulate immune response pathways to prevent hyperactive immune activity from damaging healthy tissues. In cancer patients, targeting these key molecules may serve as a valuable therapeutic mechanism to bolster immune function and restore the body’...
Autores principales: | Choe, Deborah, Choi, Dongwon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900175/ https://www.ncbi.nlm.nih.gov/pubmed/36756156 http://dx.doi.org/10.3389/fonc.2023.1088038 |
Ejemplares similares
-
Rabbit CD200R binds host CD200 but not CD200-like proteins from poxviruses
por: Akkaya, Munir, et al.
Publicado: (2016) -
CD200:CD200R Interactions and Their Importance in Immunoregulation
por: Kotwica-Mojzych, Katarzyna, et al.
Publicado: (2021) -
Quantitative Assessment of CD200 and CD200R Expression in Lung Cancer
por: Vathiotis, Ioannis A., et al.
Publicado: (2021) -
CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014) -
CD200-CD200R Interaction: An Important Regulator After Stroke
por: Zhao, Xu, et al.
Publicado: (2019)